N2Tp

1 known investors

N2TP builds autonomous AI systems with formal mathematical verification for life science R&D, aiming to make AI-driven hypotheses and experiments reproducible and trustworthy. Its platform powers applications including SmartDoseAI for model-informed precision dosing of narrow-therapeutic-window drugs and the LynxDetect programmable biosensor for point-of-care diagnostics.